United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $6.17, $0.38 better than the analyst estimate of $5.79. Revenue for the quarter came in at $677.7 million versus the consensus estimate of $620.31 million.

For earnings history and earnings-related data on United Therapeutics (UTHR) click here.